# Plain RAG on Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (KDM2B, OMIM:621474)
model: gemini-3.8-flash   generated: 2026-09-28 20:53

Everything below is what the notebook's RAG cells produce for this disease,
pre-computed so you can read it before repeating the exercise with a chat LLM

## 1. The search
query: `KDM2B gene Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities`

[1] **NEURODEVELOPMENTAL DISORDER WITH CONGENITAL CARDIAC DEFECTS ...**  
    https://omim.org/entry/621474  
    A number sign (#) is used with this entry because of evidence that neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO) is caused by heterozygous mutation in the KDM2B gene (609078) on chromosome 12q24.

[2] **Entry - *609078 - LYSINE DEMETHYLASE 2B; KDM2B - OMIM**  
    https://www.omim.org/entry/609078  
    In a 7-year-old boy (P1) with neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO; 621474), van Jaarsveld et al. (2023) identified a de novo heterozygous c.1912G-A transition (c.1912G-A, NM_032590.4) in the KDM2B gene, resulting in a gly638-to-ser (G638S) substitution at a highly ...

[3] **Neurodevelopmental disorder with congenital cardiac defects ...**  
    https://www.ncbi.nlm.nih.gov/medgen/1896179  
    Atrial septal defect (ASD) is a congenital abnormality of the interatrial septum that enables blood flow between the left and right atria via the interatrial septum.

[4] **KDM2B-Related Neurodevelopmental Disorder A Case-Series ...**  
    https://pubmed.ncbi.nlm.nih.gov/41457890/  
    This case series reinforces the consistent phenotype of KDM2B-related neurodevelopmental disorder and highlights ocular and dermatologic manifestations as recurring features in affected individuals.

[5] **Delineation of a KDM2B-related neurodevelopmental disorder ...**  
    https://pubmed.ncbi.nlm.nih.gov/36322151/  
    Purpose: Pathogenic variants in genes involved in the epigenetic machinery are an emerging cause of neurodevelopment disorders (NDDs). Lysine-demethylase 2B (KDM2B) encodes an epigenetic regulator and mouse models suggest an important role during development.

[6] **Delineation of a KDM2B-related neurodevelopmental disorder ...**  
    https://www.sciencedirect.com/science/article/pii/S109836002200942X  
    We set out to determine whether KDM2B variants are associated with NDD. Through international collaborations, we collected data on individuals with heterozygous KDM2B variants. We applied methylation arrays on peripheral blood DNA samples to determine a KDM2B associated epigenetic signature.

## 2. The context handed to the model
```
[1] NEURODEVELOPMENTAL DISORDER WITH CONGENITAL CARDIAC DEFECTS ...
https://omim.org/entry/621474
A number sign (#) is used with this entry because of evidence that neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO) is caused by heterozygous mutation in the KDM2B gene (609078) on chromosome 12q24.

[2] Entry - *609078 - LYSINE DEMETHYLASE 2B; KDM2B - OMIM
https://www.omim.org/entry/609078
In a 7-year-old boy (P1) with neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO; 621474), van Jaarsveld et al. (2023) identified a de novo heterozygous c.1912G-A transition (c.1912G-A, NM_032590.4) in the KDM2B gene, resulting in a gly638-to-ser (G638S) substitution at a highly ...

[3] Neurodevelopmental disorder with congenital cardiac defects ...
https://www.ncbi.nlm.nih.gov/medgen/1896179
Atrial septal defect (ASD) is a congenital abnormality of the interatrial septum that enables blood flow between the left and right atria via the interatrial septum.

[4] KDM2B-Related Neurodevelopmental Disorder A Case-Series ...
https://pubmed.ncbi.nlm.nih.gov/41457890/
This case series reinforces the consistent phenotype of KDM2B-related neurodevelopmental disorder and highlights ocular and dermatologic manifestations as recurring features in affected individuals.

[5] Delineation of a KDM2B-related neurodevelopmental disorder ...
https://pubmed.ncbi.nlm.nih.gov/36322151/
Purpose: Pathogenic variants in genes involved in the epigenetic machinery are an emerging cause of neurodevelopment disorders (NDDs). Lysine-demethylase 2B (KDM2B) encodes an epigenetic regulator and mouse models suggest an important role during development.

[6] Delineation of a KDM2B-related neurodevelopmental disorder ...
https://www.sciencedirect.com/science/article/pii/S109836002200942X
We set out to determine whether KDM2B variants are associated with NDD. Through international collaborations, we collected data on individuals with heterozygous KDM2B variants. We applied methylation arrays on peripheral blood DNA samples to determine a KDM2B associated epigenetic signature.
```

## 3. The gene, from the sources

The *KDM2B* gene, located on chromosome 12q24, encodes the epigenetic regulator protein lysine-demethylase 2B [1, 2, 5]. Within the cell, this gene product operates as part of the epigenetic machinery, and animal models indicate it plays an important role during development [5]. Heterozygous mutations in *KDM2B* cause neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO) [1]. For instance, a de novo heterozygous c.1912G-A transition causing a G638S amino acid substitution has been identified in a patient with the disorder [2]. Pathogenic variants in this epigenetic regulator lead to neurodevelopmental conditions accompanied by a distinct, detectable epigenetic signature, with affected individuals often displaying recurring ocular and dermatologic manifestations [4, 5, 6]. The specific biochemical mechanism explaining how these variants directly produce each cardiac, renal, and ocular defect is not covered in the provided sources [1, 5].

*tokens in 725, out 1538*

## 4. The gene, closed book (no sources; beware hallucinations)

**KDM2B** encodes lysine-specific demethylase 2B (also known as FBXL10), a JmjC domain-containing histone demethylase and an F-box component of the non-canonical Polycomb repressive complex 1 (PRC1.1). 

**Function:** 
KDM2B selectively demethylates mono- and dimethylated histone H3 lysine 36 (H3K36me1/2) and binds unmethylated CpG islands via its zinc finger-CxxC domain. By recruiting PRC1.1 to target promoters, it mediates gene repression and chromatin remodeling essential for embryogenesis, neural development, and organogenesis.

**Disease Mechanism:** 
Heterozygous loss-of-function

## 5. Which patient? Three independent rounds, same prompt

### Round 1  (picked: P06)

Based on the provided sources, here is the clinical evaluation:

### 1. Patient Rule-In / Rule-Out Assessment

The sources establish that the condition (NEDCRO) is characterized by a neurodevelopmental disorder, congenital cardiac defects, and variable renal and ocular abnormalities [1, 2], with recurring dermatologic findings [4] and reports of atrial septal defects [3]. However, the sources **do not** provide formal exclusion criteria, phenotype frequency tables, or complete clinical spectrum descriptions. Therefore, no patient can be definitively ruled in or ruled out with absolute clinical certainty based solely on these texts. 

Comparing each profile against the core triad/tetrad defined in the disorder's name and descriptions [1, 2, 4]:

*   **P01**: **Cannot be ruled in or definitively ruled out.** The patient has neurodevelopmental features [1, 5], but lacks cardiac [1, 3], renal [1], and ocular [1, 4] abnormalities.
*   **P02**: **Cannot be ruled in or definitively ruled out.** Has neurodevelopmental features [1, 5], but lacks cardiac [1, 3] and renal [1] features.
*   **P03**: **Cannot be ruled in or definitively ruled out.** Presents with neurodevelopmental features and an ocular/adnexal finding (lacrimal duct atresia) [1, 4], but lacks cardiac [1, 3] and renal [1] abnormalities.
*   **P04**: **Cannot be ruled in or definitively ruled out.** Has neurodevelopmental features [1, 5], but lacks cardiac [1, 3], renal [1], and ocular [1, 4] manifestations.
*   **P05**: **Cannot be ruled in or definitively ruled out.** Exhibits neurodevelopmental delay [1, 5], but lacks cardiac [1, 3] and renal [1] findings.
*   **P06**: **Cannot be definitively ruled in, but strongly aligns.** This patient is the only one who presents with findings across all four cardinal domains of NEDCRO:
    *   *Neurodevelopmental*: Moderate intellectual disability, delayed ability to walk [1, 5]
    *   *Cardiac*: Mitral regurgitation [1]
    *   *Renal*: Pelvic kidney [1]
    *   *Ocular*: Astigmatism, hypermetropia [1, 4]  
    However, the sources do not provide molecular data or an exhaustive symptom checklist to confirm diagnosis with certainty [1, 2, 6].
*   **P07**: **Cannot be ruled in or definitively ruled out.** Has neurodevelopmental delay [1, 5] and ocular features (esotropia, ptosis, myopia) [1, 4], but lacks cardiac [1, 3] and renal [1] manifestations.
*   **P08**: **Cannot be ruled in or definitively ruled out.** Has neurodevelopmental delay [1, 5] and ocular findings (strabismus, hypermetropia) [1, 4], but lacks cardiac [1, 3] and renal [1] manifestations.
*   **P09**: **Cannot be ruled in or definitively ruled out.** Demonstrates neurodevelopmental delay [1, 5] and congenital cardiac defects (aortic valve stenosis, bicuspid aortic valve) [1], but lacks documented renal [1] and ocular [1, 4] abnormalities.
*   **P10**: **Cannot be ruled in or definitively ruled out.** Has neurodevelopmental features [1, 5], but entirely lacks cardiac [1, 3], renal [1], and ocular [1, 4] features.

---

### 2. Single Most Likely Patient and Estimated Probability

*   **Most Likely Patient:** **P06**
*   **Estimated Probability:** **~90–95%**
    *   *Rationale:* Given that exactly one patient in the cohort has NEDCRO, P06 is the only individual whose clinical profile accounts for all aspects of the defining phenotype: a neurodevelopmental disorder, a congenital cardiac defect (mitral regurgitation), a renal abnormality (pelvic kidney), and ocular abnormalities (astigmatism, hypermetropia) [1, 2, 4]. A small margin of uncertainty remains because the sources state that renal and ocular abnormalities are "variable" [1, 2], meaning another patient with an incomplete presentation (such as P09) could theoretically have the condition if penetrance is incomplete.

---

### 3. Missing Facts Needed to Be Confident

To establish a definitive diagnosis, the following information (not provided in the sources) is required:
1.  **Molecular Genetic Testing:** Confirmation of a heterozygous pathogenic or likely pathogenic variant in the *KDM2B* gene (chromosome 12q24) [1, 2, 6].
2.  **Epigenetic Profiling:** Peripheral blood DNA methylation array results to evaluate for the specific *KDM2B*-associated episignature [6].
3.  **Inheritance Data:** Family/parental genetic testing to determine if the variant is de novo (as noted in known cases) or inherited [2].
4.  **Phenotypic Penetrance Data:** Specific clinical frequencies, detailed inclusion/exclusion criteria, and whether congenital heart defects, renal malformations, or ocular abnormalities are obligate features or have reduced penetrance in *KDM2B*-related disorder [1, 2, 4].

--------------------------------------------------------------------------------

### Round 2  (picked: P06)

Based on the provided sources, here is the clinical genetic evaluation:

### 1. Patient Evaluation (Rule In / Rule Out)

The provided sources define the condition as **neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities (NEDCRO)** caused by heterozygous *KDM2B* variants [1, 2], with recurring ocular manifestations [4] and congenital heart defects (e.g., atrial septal defect) [3]. 

The sources do not provide exhaustive inclusion/exclusion criteria or individual patient genotypes [1–6]. Because renal and ocular features are described as "variable" [1, 2], the absence of a specific feature cannot definitively rule out a diagnosis, nor can clinical features alone definitively rule it in without genetic confirmation [1, 2]. Therefore, strictly based on the text provided:

* **P01:** **Cannot definitively rule in or out.** P01 has neurodevelopmental features [1, 5, 6], but lacks the cardinal cardiac, renal, or ocular features cited in the disorder's name [1, 2]. The sources do not provide exclusionary criteria [1–6].
* **P02:** **Cannot definitively rule in or out.** Has neurodevelopmental features [1, 5, 6], but lacks cardiac, renal, and ocular features [1, 2].
* **P03:** **Cannot definitively rule in or out.** Has neurodevelopmental features and an ocular-related anomaly (lacrimal duct atresia) [1, 4], but lacks cardiac and renal findings [1, 2].
* **P04:** **Cannot definitively rule in or out.** Has neurodevelopmental features [1, 5, 6], but lacks cardiac, renal, and ocular findings [1, 2].
* **P05:** **Cannot definitively rule in or out.** Has neurodevelopmental features [1, 5, 6], but lacks cardiac, renal, and ocular manifestations [1, 2].
* **P06:** **Cannot definitively rule in or out, but is the strongest phenotypic match.** P06 exhibits features spanning all four defining domains of NEDCRO: neurodevelopmental (moderate intellectual disability, delayed walking, ataxia), cardiac (mitral regurgitation), renal (pelvic kidney), and ocular (astigmatism, hypermetropia) [1, 2, 4]. Definitive rule-in is not possible because the sources require a *KDM2B* variant for confirmed diagnosis [1, 2].
* **P07:** **Cannot definitively rule in or out.** Has neurodevelopmental and ocular features (ptosis, myopia, esotropia) [1, 4], but lacks cardiac and renal abnormalities [1, 2].
* **P08:** **Cannot definitively rule in or out.** Has neurodevelopmental and ocular features (strabismus, hypermetropia) [1, 4], but lacks cardiac and renal abnormalities [1, 2].
* **P09:** **Cannot definitively rule in or out.** Has neurodevelopmental and congenital cardiac features (aortic valve stenosis, bicuspid aortic valve) [1–3], but lacks renal or ocular abnormalities [1, 2, 4].
* **P10:** **Cannot definitively rule in or out.** Presents solely with neurodevelopmental features [1, 5, 6] without cardiac, renal, or ocular findings [1, 2].

---

### 2. Single Most Likely Patient and Estimated Probability

* **Most Likely Patient:** **P06**
* **Estimated Probability:** **~95%** (given the premise that exactly one patient in the cohort has NEDCRO). P06 is the only patient exhibiting manifestations across all four cardinal domains stated in the disorder's designation: neurodevelopmental delay, cardiac defect, renal anomaly (pelvic kidney), and ocular anomalies [1, 2, 4].

---

### 3. Missing Information Needed to Be Confident

To establish a definitive clinical and molecular diagnosis, the following information is required that the provided sources do not contain:
1. **Genetic Testing:** Molecular confirmation of a heterozygous pathogenic or likely pathogenic variant in the *KDM2B* gene (chromosome 12q24) for the patient [1, 2, 6].
2. **Epigenetic Signature:** Methylation array analysis demonstrating the *KDM2B*-associated episignature [6].
3. **Comprehensive Clinical Phenotyping Criteria:** Full phenotypic spectrum, frequency tables, and formal minimal diagnostic criteria for NEDCRO to determine whether specific non-cardiac or non-renal presentations qualify [1, 4].

--------------------------------------------------------------------------------

### Round 3  (picked: P06)

Based on the provided sources, here is the clinical genetic assessment:

### 1. Patient Rule-In / Rule-Out Assessment

The provided sources define NEDCRO as a **neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities** caused by heterozygous variants in *KDM2B* [1, 2], noting recurrent ocular features [4] and atrial septal defects [3]. 

However, **the sources do not provide comprehensive clinical criteria, phenotypic frequency tables, or formal exclusion criteria** to definitively rule patients in or out [1–6]. Based strictly on alignment with the disorder name and features explicitly mentioned in the sources:

* **P01:** **Cannot be definitively ruled in or out** [1–6]. P01 has neurodevelopmental features, but completely lacks the congenital cardiac defects, renal abnormalities, or ocular abnormalities described in the disorder definition [1, 2, 4].
* **P02:** **Cannot be definitively ruled in or out** [1–6]. P02 has neurodevelopmental manifestations, but lacks cardiac, renal, and ocular abnormalities [1, 2, 4].
* **P03:** **Cannot be definitively ruled in or out** [1–6]. While P03 has neurodevelopmental delay and a tear duct abnormality (lacrimal duct atresia) [1, 4], cardiac and renal abnormalities are absent [1, 2].
* **P04:** **Cannot be definitively ruled in or out** [1–6]. P04 has neurodevelopmental features, but lacks cardiac, renal, and ocular abnormalities [1, 2, 4].
* **P05:** **Cannot be definitively ruled in or out** [1–6]. P05 shows neurodevelopmental abnormalities, but lacks cardiac, renal, and ocular abnormalities [1, 2, 4].
* **P06:** **Cannot be definitively ruled in or out based solely on the text** [1–6], but is the **only compatible profile** with the condition's full definition. P06 possesses manifestations across all four cardinal domains specified in the disorder name and text: neurodevelopmental impairment (delayed ability to walk, moderate intellectual disability), a cardiac defect (mitral regurgitation), a renal abnormality (pelvic kidney), and ocular abnormalities (astigmatism, hypermetropia) [1, 2, 4].
* **P07:** **Cannot be definitively ruled in or out** [1–6]. P07 exhibits neurodevelopmental and ocular features (esotropia, ptosis, myopia) [1, 4], but lacks congenital cardiac and renal abnormalities [1, 2].
* **P08:** **Cannot be definitively ruled in or out** [1–6]. P08 has neurodevelopmental and ocular features (strabismus, hypermetropia) [1, 4], but lacks cardiac and renal abnormalities [1, 2].
* **P09:** **Cannot be definitively ruled in or out** [1–6]. P09 has neurodevelopmental and congenital cardiac defects (aortic valve stenosis, bicuspid aortic valve) [1, 2], but lacks renal and ocular abnormalities [1, 2, 4].
* **P10:** **Cannot be definitively ruled in or out** [1–6]. P10 presents with neurodevelopmental features only and lacks cardiac, renal, and ocular abnormalities [1, 2, 4].

---

### 2. Most Likely Patient and Estimated Probability

* **Most Likely Patient:** **P06**
* **Estimated Probability:** **~95%**
  * *Reasoning:* We are given that exactly one patient in the cohort has NEDCRO (*KDM2B*). P06 is the only individual whose phenotype encompasses all four cardinal features that define the disorder: neurodevelopmental delay, cardiac defect, renal anomaly, and ocular anomalies [1, 2, 4]. The remaining probability reflects the fact that the sources explicitly note renal and ocular anomalies can be "variable" [1, 2], leaving open a minor theoretical possibility that a patient lacking one or more of these variable features (such as P09) could be affected.

---

### 3. Missing Information Needed for Diagnostic Certainty

To establish diagnosis with certainty, the following information (not provided in sources [1–6]) is required:
1. **Molecular Genetic Confirmation:** Presence of a heterozygous (typically *de novo*) pathogenic or likely pathogenic variant in *KDM2B* [1, 2, 5, 6].
2. **Epigenetic Signature:** Peripheral blood DNA methylation array results demonstrating the established *KDM2B* episignature [6].
3. **Comprehensive Phenotypic Spectrum & Frequencies:** Detailed phenotypic delineation and minimal clinical diagnostic criteria for NEDCRO, including the penetrance of specific cardiac (beyond ASD [3]), renal, ocular, and dermatologic anomalies [1, 2, 4].

--------------------------------------------------------------------------------

picks across rounds: ['P06', 'P06', 'P06']
